Asker Healthcare Cash Flow Conversion Efficiency
Asker Healthcare cash flow conversion efficiency. Based on the latest financial reports, Asker Healthcare (ASKER) has a cash flow conversion efficiency ratio of 0.013x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr93.00 Million ≈ $10.01 Million USD) by net assets (Skr7.02 Billion ≈ $755.36 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Asker Healthcare (2021–2025)
Cash flow conversion efficiency of Asker Healthcare from 2021 to 2025. This chart illustrates how Asker Healthcare's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ASKER stock price for real-time trading data and today's change.
Asker Healthcare Cash Flow Conversion Ratio Explained
Asker Healthcare cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Asker Healthcare Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Asker Healthcare ranked by their cash flow conversion efficiency. Also see market value of Asker Healthcare for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zhefu Holding Group Co Ltd
SHE:002266
|
-0.056x |
|
APERAM S.A. NY SHS/1 O.N.
F:7AAN
|
0.042x |
|
XINYI SOLAR UNSP.ADR/20
F:13X0
|
N/A |
|
Escorts Kubota Limited
NSE:ESCORTS
|
0.040x |
|
El Al Israel Airlines Ltd
TA:ELAL
|
0.127x |
|
Chenzhou Jingui Silver Industry Co Ltd
SHE:002716
|
0.008x |
|
Callaway Golf Company
NYSE:CALY
|
0.115x |
|
China International Marine Containers (Group) Co. Ltd
F:OCM
|
0.009x |
Annual Cash Flow Conversion Efficiency for Asker Healthcare (2021–2025)
The table below shows the annual cash flow conversion efficiency of Asker Healthcare from 2021 to 2025. Review free cash flow generation of Asker Healthcare to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr6.59 Billion ≈ $708.97 Million |
Skr1.33 Billion ≈ $142.91 Million |
0.202x | -42.47% |
| 2024-12-31 | Skr3.50 Billion ≈ $376.87 Million |
Skr1.23 Billion ≈ $132.04 Million |
0.350x | +1.28% |
| 2023-12-31 | Skr3.04 Billion ≈ $327.26 Million |
Skr1.05 Billion ≈ $113.21 Million |
0.346x | -1.07% |
| 2022-12-31 | Skr2.79 Billion ≈ $300.36 Million |
Skr976.00 Million ≈ $105.03 Million |
0.350x | +66.61% |
| 2021-12-31 | Skr1.82 Billion ≈ $195.86 Million |
Skr382.00 Million ≈ $41.11 Million |
0.210x | -- |
About Asker Healthcare
Asker Healthcare Group AB (publ) provides medical supplies, devices, and equipment and related solutions that support patient care. The company supplies and distributes fittings and equipment; veterinary equipment; surgical and diagnostic instruments; medical supplies and equipment for urology, ultrasound diagnostics, laser treatment, and regenerative medicine; medical equipment for operating roo… Read more